Talking about Canadian pharmacy, some important facts should be noted.
- Canada is one of the main exporters of pharmaceutical products all over the world. It is the top 10 countries in the world with the largest number of drug sales.
- Companies are constantly working to invent improved therapies and effective medicines that will have an impact on the treatment of serious diseases, including gene and cell therapies.
- Canadian pharmacies are one of the largest suppliers of generics. These are the same effective medicines that, in terms of their mechanism of action and effectiveness, are not inferior to branded medicines. Total Canadian Pharmaceutical Business R&D Expenditure has decreased due to the active manufacturing of generics.
- According to statistics, the number of workers in Canadian pharmacology has grown by 15.5% over the past five years.
- Canada has a system of universal free health care Medicare, which provides about 70% of the population’s needs for medical services. That is why Canadian citizens have the opportunity to purchase the necessary expensive drugs for free — they are fully paid for by insurance.
- The international trade is available in Canadian pharmacies. This fact helps both to improve the economy of the country and to supply customers all over the world with highly-qualitative products.
The impact of Canadian pharmacy
Adherence to health industry regulations is also one of our principles. All the workers of the company should ensure privacy and proper care for every customer. The main law regulation is HIPPA. It serves as the principal document for all healthcare organizations.
No less important is taking care of the company’s workers. They should also have good working conditions. There is a special document that regulates working in the healthcare industry, managing contagious illnesses and agents, using x-ray machines, and other safety procedures.
If we talk about pharmaceutical manufacturing regulation, it should be noted that the concepts of industrial production of medicines and their manufacture in pharmacies are clearly separated, as reflected in a number of regulations. A drug manufactured in a pharmacy from a registered active pharmaceutical ingredient (API) should not receive FDA registration, which is a strict mandatory requirement for a drug manufactured by a pharmaceutical company. Canadian pharmacies do not receive a manufacturing license but are accredited at the state, provincial, or territory level as pharmacy establishments.
The document that indicates to the pharmacist what to prepare is a prescription issued by a doctor. Not the desire of the patient and not the initiative of the pharmacist (with the exception of over-the-counter drugs), but a correctly written prescription.
The key document regulating the pharmaceutical production of drugs in Canada is the Pharmacopeia, which describes the basic rules for the operation of pharmacies with manufacturing departments at the country level; the rest is regulated by the laws of individual states. Each state has a college of pharmacists, which has the right to impose local requirements for the organization of pharmacy production of drugs.
In the Pharmacopoeia, general principles for extemporaneous manufacturing of drugs are described. For example, pharmacy personnel with manufacturing departments must be appropriately qualified; manufactured drugs must be of acceptable concentration, quality, and purity; appropriate packaging and labeling must be used; dispersion medium must comply with its intended purpose; etc. This section also provides guidance on the selection of ingredients for pharmaceutical preparation, preferably the use of substances of purity grades provided for by the Pharmacopeia or the National Formulary.